REGEN BIOPHARMA, INC.

RGBP ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2017

Total Assets: $944.2K

Liabilities Breakdown FY2017

Total Liabilities: $6.2M